Skip to main content
Fig. 4 | Retrovirology

Fig. 4

From: The key amino acid sites 199–205, 269, 319, 321 and 324 of ALV-K env contribute to the weaker replication capacity of ALV-K than ALV-A

Fig. 4

Analysis of the binding of a recombinant chimeric ALV-A/K gp85 protein for the Tva receptor. a Homology comparison between ALV-A RSA and ALV-K GDFX0602 gp85 protein sequences; b technology roadmap of co-IP and competitive blocking tests; c, d binding of recombinant chimeric fragments s1–s5 of the Agp85 protein to the Tva receptor and relative grey values; e, f binding of recombinant chimeric fragments s1–s5 of the Agp85 protein to the Tva receptor and relative grey values; g Competitive blocking of a recombinant chimeric ALV-A/K gp85 protein. Three independent experiments were performed, and the data are shown as the mean ± SD of triplicate samples from a representative experiment. Statistical analysis (two-way analysis of variance) was performed using GraphPad Prism 7; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page